2016 Exhibitors Testimonials


In Europe today, Pharmapack is one of the most, or even THE most important event in the field of pharma packaging & drug delivery. It’s only the second time that we exhibit and we have a lot of meetings with potential and existing customers. We came as visitors since the beginning but now our products are ready for commercialization and it is important to present them to the public.

Vincent Tempelaere, CEO, Eveon

Logo Groupe JBT

We exhibited with Pharmapack for the first time twelve years ago, so we have a long experience of Pharmapack. Pharmapack is the most important exhibition for our group. It is important to be here, to build relationships with our existing customers and also to build new relationships with future customers. Pharmapack grows bigger and bigger with more and more exhibitors. It is the place to be for our market and for our business.

Jean-Charles Blanc, Sales Manager, Groupe JBT

Logo Nemera

It is a unique opportunity for us to be at Pharmapack: in two days you meet most of the pharmaceutical packaging industry. We had the opportunity to meet people from all over the world.

We have seen the transformation of Pharmapack. I remember in 1997, the first edition, we were not a lot of exhibitors. Since then Pharmapack became a really significant exhibition in the pharmaceutical world and for us it is key to be there and to exhibit at Pharmapack.

Nicolas Flexas, Sales Director, Nemera

Logo Paperpack

This is our fifth year at Pharmapack, we are quite loyal. 10 years ago we have decided to invest in the pharma sector, a very dynamic and constantly growing sector with high standards of quality. We want to expand our business internationally. This particular exhibition is a very good opportunity for us because the visitors are very specialized, they know what they want, and most of the meetings you have are qualitative meetings.

Dimitris Tsiftsis, Sales Manager, Paperpack

Logo Pylote

After our successful capital increase in January, Pharmapack Europe was an essential step for the development of Pylote. This event allowed us to showcase our innovative solution Pyclear Protection to the European market across all its segments.

Loïc Marchin, CEO, Pylote

Logo Aptar Stelmi

This is an unmissable platform for pharmaceutical packaging networking.

Anne Bailly, Product Communication Manager, Aptar Stelmi

Logo Cryopak

Pharmapack has been a great experience for us. We are really satisfied with the organisation of the show.You learn something new every day, Pharmapack is a great place to do just that.

Ursula Amat, Sales and Marketing Manager, Cryopak Europe

Logo CSP Technologies

Pharmapack is in my mind one of the most valuable trade show for Pharma packaging.

Cédric Bourgeois, Business Development Manager, CSP Technologies


All main players in drug delivery/pharma packaging are there as exhibitors or visitors . Many contacts in a single place within 2 days.

Laurent Hahnen, Development Program Manager, DUPONT

Logo Injecto

Good balance between small and large companies. A lot of exposure and attendance. All major players in the industry are represented.

John Adamsen, Chief Legal Officer, Injecto

Logo Nelipak

It's the best show for this industry. The attendees are the people we are looking to meet and the networking is great.

Angela Shotton, Area Sales Manager, Nelipak Healthcare Packaging

Logo Symatese

Pharmapack is clearly the key event bringing together all actors involved in the design and manufacture of pharma packaging & medical devices.

Mickael Rouach, Sales Development Manager, Symatese

Logo Toxikon Europe

As part of a CRO investigating pharma packaging, our customers are almost all present at Pharmapack. This is both a good meeting place to meet with customers of ours and to make contact with new customers. Pharmapack also gives a good overview of the new developments, making it an excellent opportunity for the customers and sales department to come together and discuss future collaborations. Pharmapack is also a good place for us to understand what direction the CRO should envision as we depend on both the guidelines and the novel developments on the market.

Wim Van Rossom, Doctor, Toxikon Europe